ClinicalTrials.gg
Sign In

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma clinical trials

The registry lists 38 studies for Precursor B-Cell Lymphoblastic Leukemia-Lymphoma across more than 10 countries. 16 are recruiting or about to start. 14 of them are mainly about Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Precursor B-Cell Lymphoblastic Leukemia-Lymphoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting
12
Completed
9
Active, not recruiting
6
Not yet recruiting
4
Terminated
3
Withdrawn
2

Phase

Phase 2
23
Phase 1
15
Phase 3
5
Phase 4
1

Where

United States
19
China
6
Puerto Rico
6
France
5
Australia
4
Spain
4

Who runs them

Princess Maxima Center for Pediatric Oncology (5) · Children's Oncology Group (3) · University of Washington (3) · First Affiliated Hospital of Zhejiang University (3) · Medical College of Wisconsin (2) · Seagen Inc. (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Shanghai Children's Medical Center (1)

What is being tested here

Drugs under test in Precursor B-Cell Lymphoblastic Leukemia-Lymphoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cyclophosphamide428
Blinatumomab436
Venetoclax406
Inotuzumab Ozogamicin317
Cytarabine325
Dexamethasone304
Doxorubicin124
Thioguanine133
Fludarabine101
BEBT-908101

Drug classes tested here Antimetabolites 5 open · Corticosteroids 3 open · Tyrosine kinase inhibitors (TKIs) 3 open · Antimitotic agents 3

Coming up

4phase 3 studies under way
10studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10, phase 3 first

Who these studies take

Of the 12 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma studies recruiting now, 4 (33%) set no upper age limit and 8 (67%) stop at 75 or younger. 9 (75%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
105 (42%)5 (42%)
1811 (92%)11 (92%)
306 (50%)6 (50%)
407 (58%)7 (58%)
507 (58%)7 (58%)
656 (50%)6 (50%)
754 (33%)4 (33%)
854 (33%)4 (33%)

Across all 38 studies, recruiting or not: 55% stop at 75 or younger and 42% at 65; 58% take children; 0% are for women only and 0% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 38 of 38. search them.